Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C40H52O4 |
Molecular Weight | 596.8385 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 9 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(\C=C\C=C(C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)[C@@H](O)CC2(C)C
InChI
InChIKey=MQZIGYBFDRPAKN-UWFIBFSHSA-N
InChI=1S/C40H52O4/c1-27(17-13-19-29(3)21-23-33-31(5)37(43)35(41)25-39(33,7)8)15-11-12-16-28(2)18-14-20-30(4)22-24-34-32(6)38(44)36(42)26-40(34,9)10/h11-24,35-36,41-42H,25-26H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,27-15+,28-16+,29-19+,30-20+/t35-,36-/m0/s1
Molecular Formula | C40H52O4 |
Molecular Weight | 596.8385 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 9 |
Optical Activity | UNSPECIFIED |
Astaxanthin (ATX), a red-orange carotenoid that originates the pink or red color of salmon, trout, lobster, shrimp, and other sea organisms, exhibits antioxidant, anti-inflammatory, and antiapoptotic effects. Recently, ATX was shown to protect neurons in experimental models of acute injuries, chronic neurodegenerative disorders, and neurological diseases and was proposed as a beneficial strategy to treat neurological diseases. In addition, ATX chelates several metal ions, preventing metal ion-induced oxidative stress, it has anti-inflammatory properties and it acts as a damper of singlet oxygen levels. Being a part of naturally derived supplements Oncotris™ in genitourinary cancer patients was revealed, that astaxanthin could support the body to overcome the treatment-related toxicities - and the relative oxidative stress in cancer patients.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study. | 2017 Sep |
|
Valorization of raw materials from agricultural industry for astaxanthin and β-carotene production by Xanthophyllomyces dendrorhous. | 2018 Jul |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29028078
astaxanthin (Oncotris™) used as supplementary management in genitourinary cancer patients who had undergone oncological therapy
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27034843
There were investigated whether the antioxidant agent astaxanthin (ATX) protects neurons from AβOs-induced excessive mitochondrial ROS generation, NFATc4 activation, and RyR2 mRNA downregulation. Primary hippocampal cultures were incubated with 0.1 μM ATX for 1.5 h prior to AβOs addition (500 nM). It was found that incubation with ATX (≤10 μM) for ≤24 h was nontoxic to neurons, evaluated by the live/dead assay. Preincubation with 0.1 μM ATX also prevented the neuronal mitochondrial H2O2 generation induced within minutes of AβOs addition. Longer exposures to AβOs (6 h) promoted NFATc4-eGFP nuclear translocation and decreased RyR2 mRNA levels, evaluated by detection of the eGFP-tagged fluorescent plasmid and qPCR, respectively. Preincubation with 0.1 μM ATX prevented both effects. These results indicate that ATX protects neurons from the noxious effects of AβOs on mitochondrial ROS production, NFATc4 activation, and RyR2 gene expression downregulation.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:37:01 GMT 2023
by
admin
on
Fri Dec 15 17:37:01 GMT 2023
|
Record UNII |
8XPW32PR7I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C68309
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
||
|
NCI_THESAURUS |
C210
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
||
|
DSLD |
12 (Number of products:746)
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
207-451-4
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
DB06543
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
SUB21932
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
DTXSID00893777
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
100000091870
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
472-61-7
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
C63653
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
m2115
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | Merck Index | ||
|
C005948
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
7468
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
40968
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
8XPW32PR7I
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
635689
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
18451
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | RxNorm | ||
|
1044200
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
5281224
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
8XPW32PR7I
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY | |||
|
ASTAXANTHIN
Created by
admin on Fri Dec 15 17:37:01 GMT 2023 , Edited by admin on Fri Dec 15 17:37:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
Unit: ng/g; The content of carotenoids from selected commercially available health supplements (Spirulina)
ASSAY (HPLC)
Batch Data
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |